These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22491465)

  • 21. Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial.
    Bernstein DI; Wald A; Warren T; Fife K; Tyring S; Lee P; Van Wagoner N; Magaret A; Flechtner JB; Tasker S; Chan J; Morris A; Hetherington S
    J Infect Dis; 2017 Mar; 215(6):856-864. PubMed ID: 28329211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of Herpes Simplex Virus Glycoprotein D Antibodies to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines.
    Mahant AM; Guerguis S; Blevins TP; Cheshenko N; Gao W; Anastos K; Belshe RB; Herold BC
    J Infect Dis; 2022 Nov; 226(9):1489-1498. PubMed ID: 35834278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological impact of a genital herpes type 2 vaccine for young females.
    Lou Y; Qesmi R; Wang Q; Steben M; Wu J; Heffernan JM
    PLoS One; 2012; 7(10):e46027. PubMed ID: 23071536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains.
    Diaz F; Gregory S; Nakashima H; Viapiano MS; Knipe DM
    Virology; 2018 Jan; 513():129-135. PubMed ID: 29069622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.
    Petro C; González PA; Cheshenko N; Jandl T; Khajoueinejad N; Bénard A; Sengupta M; Herold BC; Jacobs WR
    Elife; 2015 Mar; 4():. PubMed ID: 25756612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A HSV1 mutant leads to an attenuated phenotype and induces immunity with a protective effect.
    Xu X; Feng X; Wang L; Yi T; Zheng L; Jiang G; Fan S; Liao Y; Feng M; Zhang Y; Li D; Li Q
    PLoS Pathog; 2020 Aug; 16(8):e1008703. PubMed ID: 32776994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of recombinant rotavirus carrying herpes simplex virus 2 glycoprotein D gene based on reverse genetics technology.
    Kawamura Y; Komoto S; Fukuda S; Kugita M; Tang S; Patel A; Pieknik JR; Nagao S; Taniguchi K; Krause PR; Yoshikawa T
    Microbiol Immunol; 2024 Feb; 68(2):56-64. PubMed ID: 38098134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivo.
    Aubert M; Haick AK; Strongin DE; Klouser LM; Loprieno MA; Stensland L; Santo TK; Huang ML; Hyrien O; Stone D; Jerome KR
    Nat Commun; 2024 May; 15(1):4018. PubMed ID: 38740820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HSV-2 Cellular Programming Enables Productive HIV Infection in Dendritic Cells.
    Crisci E; Svanberg C; Ellegård R; Khalid M; Hellblom J; Okuyama K; Bhattacharya P; Nyström S; Shankar EM; Eriksson K; Larsson M
    Front Immunol; 2019; 10():2889. PubMed ID: 31867020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages.
    Sartori E; Calistri A; Salata C; Del Vecchio C; Palù G; Parolin C
    Virol J; 2011 Apr; 8():166. PubMed ID: 21486479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B.
    Casto AM; Huang MW; Xie H; Jerome KR; Wald A; Johnston CM; Greninger AL
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32781734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoregulatory Functions of Interferons During Genital HSV-2 Infection.
    Feng E; Balint E; Vahedi F; Ashkar AA
    Front Immunol; 2021; 12():724618. PubMed ID: 34484233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of herpes simplex virus 1 genomic diversity between adult sexual transmission partners with genital infection.
    Rathbun MM; Shipley MM; Bowen CD; Selke S; Wald A; Johnston C; Szpara ML
    PLoS Pathog; 2022 May; 18(5):e1010437. PubMed ID: 35587470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral Spread to Enteric Neurons Links Genital HSV-1 Infection to Toxic Megacolon and Lethality.
    Khoury-Hanold W; Yordy B; Kong P; Kong Y; Ge W; Szigeti-Buck K; Ralevski A; Horvath TL; Iwasaki A
    Cell Host Microbe; 2016 Jun; 19(6):788-99. PubMed ID: 27281569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.
    Chentoufi AA; Benmohamed L
    Clin Dev Immunol; 2012; 2012():149135. PubMed ID: 23320014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting apoptosis in neurological disease using the herpes simplex virus.
    Perkins D
    J Cell Mol Med; 2002; 6(3):341-56. PubMed ID: 12417051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa.
    Freeman EE; White RG; Bakker R; Orroth KK; Weiss HA; Buvé A; Hayes RJ; Glynn JR
    Vaccine; 2009 Feb; 27(6):940-6. PubMed ID: 19071187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes.
    Antoine TE; Hadigal SR; Yakoub AM; Mishra YK; Bhattacharya P; Haddad C; Valyi-Nagy T; Adelung R; Prabhakar BS; Shukla D
    J Immunol; 2016 Jun; 196(11):4566-75. PubMed ID: 27183601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An mRNA vaccine to prevent genital herpes.
    Awasthi S; Friedman HM
    Transl Res; 2022 Apr; 242():56-65. PubMed ID: 34954087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection, activity, and nuclease stabilization of cross-neutralizing DNA aptamers targeting HSV-1 and HSV-2.
    Schump MD; Bernstein DI; Bravo FJ; Neff CP
    Virology; 2024 Jan; 589():109916. PubMed ID: 37925791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.